Laboratory Corporation Of America Holdings (LH): Today's Featured Health Services Winner

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Laboratory Corporation of America Holdings ( LH) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day down 0.1%. By the end of trading, Laboratory Corporation of America Holdings rose $1.27 (1.4%) to $95.32 on average volume. Throughout the day, 1,030,830 shares of Laboratory Corporation of America Holdings exchanged hands as compared to its average daily volume of 1,170,800 shares. The stock ranged in a price between $94.18-$95.48 after having opened the day at $94.49 as compared to the previous trading day's close of $94.05. Other companies within the Health Services industry that increased today were: Retractable Technologies ( RVP), up 8.3%, Huttig Building Products ( HBP), up 7.3%, InfuSystems Holdings ( INFU), up 7.1% and Arrhythmia Research Technology ( HRT), up 6.8%.

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. Laboratory Corporation of America Holdings has a market cap of $8.0 billion and is part of the health care sector. Shares are up 2.4% year to date as of the close of trading on Thursday. Currently there are 5 analysts that rate Laboratory Corporation of America Holdings a buy, 2 analysts rate it a sell, and 11 rate it a hold.

TheStreet Ratings rates Laboratory Corporation of America Holdings as a buy. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, revenue growth, notable return on equity, increase in net income and expanding profit margins. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated.

On the negative front, Baxano Surgical ( BAXS), down 11.4%, Synergetics USA ( SURG), down 11.2%, AcelRx Pharmaceuticals ( ACRX), down 8.4% and AxoGen ( AXGN), down 7.6% , were all laggards within the health services industry with St Jude Medical ( STJ) being today's health services industry laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

Good, the Bad and the Ugly; What Troubles Me: Doug Kass' Views

Amid M&A Buzz, LabCorp CEO Says Deal Pipeline 'Very Healthy'

INC Research Holdings Seen as Likely LabCorp. Takeover Target

5 Big Stocks to Buy for Big Gains

Laboratory Corp Of America Holdings (LH) Hits New Lifetime High Today